Provided by Tiger Fintech (Singapore) Pte. Ltd.

SAB Biotherapeutics, Inc.

1.66
-0.1349-7.54%
Volume:11.60K
Turnover:19.79K
Market Cap:15.37M
PE:-0.45
High:1.78
Open:1.64
Low:1.64
Close:1.79
Loading ...
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 22, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Oct 21, 2021

Major Issues Report

8-K - Current report
Oct 19, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 13, 2021

Major Issues Report

8-K - Current report
Oct 13, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Oct 12, 2021

Major Issues Report

8-K - Current report
Oct 12, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Oct 07, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Oct 04, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 28, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 27, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 22, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 16, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2021

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 07, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Aug 17, 2021

Correspondence

CORRESP [Cover] - Correspondence